Effect of Orally Active Prostacyclin Analogue on Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension Without Major Vessel Obstruction

An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension

1992 • 1,180 citations

Longterm Follow-up of Patients with Pulmonary Thromboembolism

1982 • 800 citations

A memorable patient: Long term follow up

1999 • 690 citations

Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension

1998 • 674 citations

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

2002 • 639 citations

Pulmonary Vascular Lesions Occurring in Patients With Chronic Major Vessel Thromboembolic Pulmonary Hypertension

1993 • 611 citations

Chronic major-vessel thromboembolic pulmonary hypertension.

1990 • 485 citations

Prognostic Factors in Medically Treated Patients With Chronic Pulmonary Embolism

2001 • 367 citations

Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period

1993 • 343 citations

Long-Term Outcome after Pulmonary Thromboendarterectomy

1999 • 321 citations

Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion

1997 • 307 citations

Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography.

1992 • 305 citations

The Management Task

2007 • 257 citations

Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series

1999 • 219 citations

Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension

1998 • 211 citations

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension

1999 • 208 citations

Reliability of the Determination of Cardiac Output in Man by Means of the Fick Principle

1958 • 82 citations

Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension

2002 • 69 citations

General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.

1989 • 38 citations

The management of pulmonary hypertension secondary to chronic thromboembolic disease

1994 • 30 citations

Orally Administered Beraprost Sodium Inhibits Pulmonary Hypertension Induced by Monocrotaline in Rats.

1994 • 24 citations